Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,102 INR | -0.57% | -0.23% | +6.05% |
May. 16 | Transcript : Mankind Pharma Limited, Q4 2024 Earnings Call, May 16, 2024 | |
May. 16 | Mankind Pharma's Consolidated Profit Jumps in Fiscal Q4 | MT |
Sales 2024 | 103B 1.24B | Sales 2025 * | 116B 1.4B | Capitalization | 847B 10.16B |
---|---|---|---|---|---|
Net income 2024 | 19.13B 230M | Net income 2025 * | 22.08B 265M | EV / Sales 2024 | 8.92 x |
Net cash position 2024 * | 25.25B 303M | Net cash position 2025 * | 42.36B 508M | EV / Sales 2025 * | 6.92 x |
P/E ratio 2024 |
48.3
x | P/E ratio 2025 * |
38.4
x | Employees | 18,468 |
Yield 2024 * |
0.29% | Yield 2025 * |
0.27% | Free-Float | 19.92% |
Latest transcript on Mankind Pharma Limited
1 day | -0.57% | ||
1 week | -0.23% | ||
Current month | -11.08% | ||
1 month | -11.55% | ||
3 months | -1.55% | ||
6 months | +10.73% | ||
Current year | +6.05% |
Managers | Title | Age | Since |
---|---|---|---|
Sheetal Arora
CEO | Chief Executive Officer | 48 | 07-09-20 |
Ashutosh Dhawan
DFI | Director of Finance/CFO | 55 | 16-06-16 |
Pradeep Chugh
CMP | Compliance Officer | - | 16-09-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vivek Kalra
BRD | Director/Board Member | 60 | 22-07-31 |
Vijaya Sampath
BRD | Director/Board Member | 71 | 22-07-31 |
Surendra Lunia
BRD | Director/Board Member | 61 | 15-02-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-29 | 2,102 | -0.57% | 781 782 |
24-05-28 | 2,114 | +0.00% | 610,496 |
24-05-27 | 2,114 | +2.50% | 959,693 |
24-05-24 | 2,063 | -1.77% | 713,692 |
24-05-23 | 2,100 | -0.34% | 762,526 |
Delayed Quote NSE India S.E., May 29, 2024 at 06:26 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.05% | 10.18B | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.38% | 238B | |
+7.15% | 204B | |
-6.13% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |
- Stock Market
- Equities
- MANKIND Stock